# Liraglutide in Children and Adolescents with Type 2 Diabetes.

> PubMed lists PMID 31034184 in The New England journal of medicine as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-04-28 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31034184-liraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31034184-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31034184-liraglutide-v1.json
- Content SHA-256: `7c7bd1a250b427480a8ad3ccdffeb23e7b5799e0a4ff859a07d4c709f4acdfdc`

## Claims and source pins

### Headline

Liraglutide in Children and Adolescents with Type 2 Diabetes. ([`pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e`](#source-pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e))

### Summary

PubMed lists PMID 31034184 in The New England journal of medicine as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-04-28 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e`](#source-pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e))

### Paragraph 1

PubMed lists PMID 31034184 in The New England journal of medicine as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-04-28 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e`](#source-pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e`](#source-pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e))

## Sources

<a id="source-pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e"></a>
- **Liraglutide in Children and Adolescents with Type 2 Diabetes. · retained source version 1:2026-05-18:current:8b5c4909931ec813fd57aac5d5b380f79883e8998bd183435e267948e20bebd2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31034184/) (`pubmed-observation-pmid-31034184-2026-05-18-8b5c4909931e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Liraglutide in Children and Adolescents with Type 2 Diabetes." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31034184-liraglutide-v1.json SHA-256: 7c7bd1a250b427480a8ad3ccdffeb23e7b5799e0a4ff859a07d4c709f4acdfdc.